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Abstract
Background: Distant metastasis from differentiated thyroid carcinoma at presentation is rare and isolated liver
metastasis on presentation is almost unknown. We report a case of primary follicular carcinoma of the thyroid with
isolated liver metastasis at presentation.
Case presentation: A 65-year-old man of Kashmiri origin presented to our tertiary referral center with obstructive
jaundice; he was evaluated with magnetic resonance cholangiopancreatography and positron emission
tomography-computed tomography. Positron emission tomography-computed tomography documented a lesion
in his liver in addition to a metabolically active thyroid nodule. Fine needle aspiration cytology of the liver lesion
supplemented with immunohistochemical analysis using thyroid transcription factor 1 confirmed the lesion as
being an isolated metastasis from the primary thyroid lesion (which on fine needle aspiration cytology showed
follicular architecture).
Conclusions: To best of our knowledge, this is first reported case of primary differentiated thyroid carcinoma
presenting with isolated liver metastasis manifesting as obstructive jaundice.
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Background
Differentiated thyroid cancer (DTC) rarely presents with
distant metastasis at outset. In a recent Surveillance,
Epidemiology, and End Results (SEER) database study
that covered a period between 1988 and 2009, a total of
1291 patients with metastatic DTC at diagnosis were
identified, amounting to a prevalence rate of 2.2% [1].
Gastrointestinal metastases of thyroid cancer are very
uncommon and account for 0.5 to 1% of all distant me-
tastases [2]. Within the gastrointestinal system, the liver
is the most common site of secondary spread and ac-
counts for approximately 0.5% of all distant metastases
originating from DTC [3]. Massive liver involvement is
usually a late finding associated with severe symp-
tomatology and rapid progression to death [4]. Liver
metastases usually occur in the setting of widespread
metastatic disease. Very few cases (four as per our
search of medical databases) of DTC with isolated liver
metastases have been reported to date [3, 5–7], but to
the best of our knowledge none of these cases presented
with obstructive jaundice or with isolated hepatic metas-
tasis. Here we report a newly diagnosed case of follicular
thyroid carcinoma with solitary liver metastasis causing
cholestasis at presentation.
Case presentation
A 65-year-old man of Kashmiri origin with a history of
essential hypertension and type II diabetes mellitus was
referred to our out-patient department with a diagnosis
of obstructive jaundice. He had been already evaluated
with a whole body positron emission tomography-
computed tomography (PET-CT) scan. The PET-CT
scan documented a fluorodeoxyglucose (FDG) avid
space-occupying lesion in segments IV and II of his liver
that measured approximately 7.2×5.2 cm, maximum
standardized uptake value (SUVmax) of 15.6, compres-
sing his left hepatic duct (Fig. 1), along with a metabolic-
ally active thyroid nodule (SUVmax 32.0; Fig. 2). In
addition, a 2.9×2.3 cm periportal lymph node with SUV-
max 7.6 was also noted (Fig. 3). The above findings were
confirmed by magnetic resonance cholangiopancreato-
graphy (MRCP) which showed an ill-defined
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heterogeneous signal intensity mass lesion (hyperintense
on T2-weighted image and hypointense on T1-weighted
image), predominantly occupying segments II, III, IV, VI,
and VIII and measuring approximately 7.5×8.5 cm
(Fig. 4). The lesion was shown to predominantly involve
the left ductal system causing upstream dilatation. Mul-
tiple heterogeneous lymph nodes (hyperintense on T2
and diffusion-weighted imaging) were seen in his peri-
portal region. A physical examination of our patient re-
vealed icterus and mild hepatomegaly; palpation of his
neck was unremarkable. He had altered liver function
tests (LFTs) with grossly elevated bilirubin (total biliru-
bin 10.1 mg/dl, direct bilirubin 7.2 mg/dl, indirect biliru-
bin 2.90 mg/dl) and alkaline phosphatase levels. The
results of a complete blood count (CBC), coagulation
assay, and kidney function tests (KFTs) were normal.
Ultrasonography (USG)-guided fine needle aspiration
cytology (FNAC) of the liver lesion was reported as
papillary adenocarcinoma. FNAC from his thyroid was
labelled as follicular neoplasm (Bethesda IV category;
Fig. 1 18F-fluorodeoxyglucose positron emission tomography-computed tomography image showing a large heterogeneous lesion (measuring
approximately 7.2×5.2 cm, maximum standardized uptake value 15.6) in segment IV and adjacent segment II of liver
Fig. 2 18F-fluorodeoxy glucose positron emission tomography-computed tomography image showing hypodense nodule, 1.7×1.7×1.9 cm, with
increased uptake (maximum standardized uptake value 32.0) in right lobe of thyroid
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Fig. 5). An USG-guided core-cut biopsy of the liver le-
sion was carried out and hematoxylin and eosin examin-
ation of this revealed metastatic deposits of follicular
carcinoma with surrounding areas of necrosis (Figs. 6
and 7). Immunohistochemical staining of the liver biopsy
was positive for thyroid transcription factor 1 (TTF-1),
cytokeratin (CK) 19 and CK20, and negative for mucin
(MUC) 1 (Fig. 8), establishing his thyroid as the primary
source of the liver lesion.
In view of PET-CT and pathological findings he was fi-
nally diagnosed to have follicular carcinoma of the thy-
roid with isolated hepatic metastasis with obstructive
jaundice and was scheduled for total thyroidectomy
followed by radioactive I131 ablation (RIA). In view of his
altered LFTs, it was decided to subject him to preopera-
tive biliary drainage by biliary stenting. However, unfor-
tunately, post-procedure he developed acute cholangitis
and severe sepsis which proved fatal for him.
Fig. 4 Magnetic resonance cholangiopancreatography showing ill-defined heterogeneous signal intensity mass lesion, predominantly occupying
segments II, III, IV, VI, VIII and measuring approximately 7.5×8.5 cm in size
Fig. 3 18F-fluorodeoxyglucose positron emission tomography-computed tomography image showing 2.9×2.3 cm periportal lymph node with
maximum standardized uptake value 7.6
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Discussion
Isolated liver metastasis from DTC is rare and very
few cases have been reported in the medical literature.
Our search of medical databases revealed that only
four cases of DTC with isolated liver metastases have
been reported in the English medical literature until
now [3, 5–7]. It is to be noted that none of the cases
reported had liver metastasis at the time of presenta-
tion; hence, ours is the first reported case of DTC with
isolated liver metastasis at presentation which was
complicated with obstructive jaundice.
Graves et al. [5] reported a case of 36-year-old man with
an incidental finding of painless left thyroid nodule who
subsequently underwent a subtotal thyroidectomy. A
pathologic review of the excised tissue revealed a 3‐cm fol-
licular carcinoma of his left thyroid lobe with capsular and
vascular invasion. Immunohistochemical staining was
positive for thyroglobulin (Tg) and negative for calcitonin.
His serum Tg level was 25,000 ng/ml. A postoperative I131
scan (5 mCi) demonstrated uptake in his thyroid bed with
no evidence of distant metastases. There were no foci of
abnormal activity to suggest distant metastases. He was
treated with 100 mCi I131 for ablation of the remnant thy-
roid tissue. A follow‐up examination 9 months after the
initial treatment revealed a Tg level of 17,000 ng/ml. A
bone scan and chest X‐ray demonstrated normal findings
with no evidence of bone or lung metastases. A follow‐up
I131 examination (5 mCi I131) showed an intense focal area
of abnormal activity in the region of his liver, suspicious
for liver metastasis.
Kondo et al. [6] reported a case of 48-year-old Japanese
woman who was operated (subtotal thyroidectomy) for
follicular adenoma of her thyroid. Eight years after the
initial surgery, an isolated liver lesion was incidentally
detected on abdominal computed tomography (CT) scan.
The liver lesion was resected with a cuff of liver paren-
chyma and subjected to histopathological evaluation. The
tumor lacked a capsule and had an ill-defined border with
the liver tissue. On histological examination, the nodule
was entirely composed of small to large follicles contain-
ing colloid material. These follicles were lined by flat-
tened-to-cuboidal cells, having uniform and round
nuclei and non-remarkable nuclear atypia. Immunohis-
tological studies confirmed Tg, triiodothyronine (T3),
and thyroxine (T4) positivity, consistent with follicular
cells or colloid material. No mitotic activity and a low
MIB-1 positive index (<1% positive cells) were noted in
the specimen. Staining of p53 was negative. Histopath-
ology of her thyroid specimen (subtotal thyroidectomy
done 8 years earlier) was reviewed and additional sec-
tions revealed a focus of tumor thrombus in capsular
vessel which was completely enveloped by the vessel
wall endothelium. Thus she was diagnosed to have had
minimally invasive follicular carcinoma with secondary
isolated liver metastasis.
Salvatori et al. [3] described a similar case with a soli-
tary liver metastasis from Hürthle cell thyroid cancer,
which appeared during long-term follow-up. The lesion
was diagnosed by progressive increase of serum Tg and
confirmed with a positive I131 scan, USG of the abdo-
men, magnetic resonance imaging (MRI) of the liver,
and 18F-FDG-PET scan.
Kouso et al. [7] reported follicular thyroid carcinoma
in a 73-year-old woman who had undergone curative re-
section of thyroid carcinoma 32 years earlier. CT of her
abdomen revealed a round lesion, approximately 1.5 cm
Fig. 5 Thyroid aspirate showing many syncytial cell clusters forming follicles, nuclear crowding, and overlapping
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in diameter, which was enhanced early and washed out
later, in segment 5 of her liver. She underwent laparot-
omy and partial resection of her liver. Microscopic
examination showed follicular cells with minimal atypia
growing in a thyroid follicular pattern with colloid,
whereby a diagnosis of metastatic liver cancer from thy-
roid follicular carcinoma was made.
The discussion of the above four cases reveals that all
of them were recurrent cases of thyroid carcinoma. Ours
is the first reported case of primary thyroid carcinoma
presenting with isolated liver metastasis and complicated
by obstructive jaundice.
For patients with a Tg level above some arbitrary limit,
the administration of a large dose (3.7 to 5.5 GBq; 100 to
150 mCi) of I131, in order to obtain a highly sensitive
therapeutic whole body scan (WBS), remains the best
diagnostic strategy. However, on very rare occasions,
physiological enteric radioactivity can hide possible ab-
dominal lesions and further in-depth studies, such as
FDG-PET scans, are sometimes necessary.
Fig. 6 Metastatic deposits of follicular carcinoma in liver with surrounding areas of necrosis. Hematoxylin and eosin, 10×
Fig. 7 Microfollicular groups, few with abnormal colloid in small central lumen. Cells exhibiting nuclear hyperchromasia and coarse chromatin.
Hematoxylin and eosin, 40×
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Although immunohistochemical analysis was carried
out on the metastatic lesion in the case reported by
Kondo et al. [6], none of the other three reported case
had IHC done on the metastatic lesions. In our study,
IHC was done with TTF-1 marker, which was reported
as strongly positive. TTF-1 being specific to only thyroid
and lung tissue and with no lung lesion visualized on
imaging studies, diagnosis of follicular thyroid carcinoma
with isolated liver metastasis at presentation was made.
Conclusions
The present case exemplifies a very rare presentation of
DTC; however, advanced imaging techniques combined
with appropriate immunohistochemistry should be used
before labelling liver lesion as metastatic from a rare
primary site, as was done in our case.
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